InvestorsHub Logo
Followers 118
Posts 11970
Boards Moderated 0
Alias Born 12/18/2003

Re: None

Saturday, 04/20/2024 9:56:57 PM

Saturday, April 20, 2024 9:56:57 PM

Post# of 232257
Leronlimab was proven being effective many times , much more effective , imo , then some of the toxic approved drugs , and in contrary without one serious side effect .

But then Dr Jeffrey Murray working at the time in FDA , didn’t talk in his emails about other companies i as he did about CYDY …

“ I hate them ..”

Another FDA employee posted in her email , it was Susan S ( I dont remember her last name )
So she said .
— you know this drug is an immunosuppressant ,

Wow , who they have working there .

No, it is not an immunosupressant , it is an immune modulator .

FDA , know what you are talking about !!!

Leronlimab has a great results in following studies ..

—-Phase 3 pivotal study for combo HIV , finished with 81% efficacy , and not one serious side effect. When at the time 2 other approved drugs were ,maraviroc with 45% , and Ibalizumab with 43%
—- CD12 study in critical Covid showed ,
82% mortality benefit ABOVE any drug in the world , when leronlimab was in the system ..
—-small study in cancers showed really positive results …
—-as also in Nash …
-—Long Covid study was a big success , it showed that some patients immune system is hyperactive , but many are immunosuppressed , leronlimab worked as a great immunemodulator in both ..
This study was peer reviewed and published by Dr Otto Yang from UCLA..

Yes , leronlimab seems to be a great drug , much better then many approved for us toxic , doing nothing , or minimum good drugs !!


All imo

GLTA longs
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News